Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03342417
Title Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors ExcellaBio LLC
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.